1. Does your trust run a dedicated Gastroenterology infusion clinic for the treatment of patients with Infliximab [or Vedolizumab] If Yes, how frequently are they run?
2. Could you please provide me with the following numbers of patients treated in the last six months with the following drugs for the conditions listed below?

Rheumatology [Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis] Dermatology [Psoriasis] Hidradenitis suppurativa (sometimes known as acne inversa) L73.2 Gastroenterology
[Crohns / Ulcerative Colitis]
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Tocilizumab (RoActemra)
Tofacitinib [Xeljanz]
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar 120116